These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1114 related items for PubMed ID: 12235522

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Serum macrophage migration inhibitory factor (MIF) levels after allogeneic hematopoietic stem cell transplantation.
    Toubai T, Shono Y, Nishihira J, Ibata M, Suigita J, Kato N, Ohkawara T, Tone S, Lowler KP, Ota S, Tanaka J, Asaka M, Reddy P, Imamura M.
    Int J Lab Hematol; 2009 Apr; 31(2):161-8. PubMed ID: 18081874
    [Abstract] [Full Text] [Related]

  • 3. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M, Iravani M, Babaee GR, Ghavamzadeh A.
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [Abstract] [Full Text] [Related]

  • 4. Effect of macrophage migration inhibitory factor (MIF) on acute graft-versus-host disease in a murine model of allogeneic stem cell transplantation.
    Toubai T, Tanaka J, Nishihira J, Ohkawara T, Hirate D, Kondo N, Tone S, Shono Y, Ibata M, Sugita J, Kato N, Miura Y, Iwao N, Ota S, Imamura M.
    Transpl Immunol; 2006 Aug; 16(2):117-24. PubMed ID: 16860715
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 7. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
    Chen H, Huang XJ, Liu KY, Xu LP, Wang H, Liu DH, Lu J, Lu DP.
    Zhonghua Yi Xue Za Zhi; 2005 Nov 16; 85(43):3062-6. PubMed ID: 16324408
    [Abstract] [Full Text] [Related]

  • 8. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
    Lin Q, Dong M, Wang QM, Wen JY, Wu XY.
    Ai Zheng; 2006 Oct 16; 25(10):1261-5. PubMed ID: 17059772
    [Abstract] [Full Text] [Related]

  • 9. [Association between acute graft versus host disease and lung injury after allogenic hematopoietic stem cell transplantation].
    Liu QF, Luo XD, Fan ZP, Ning J, Xu D, Sun J, Zhang Y, Xu B, Wei YQ.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 03; 89(8):538-42. PubMed ID: 19567075
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [T-bet gene expression in acute graft versus host disease].
    Yan ZS, Liu QG, Yang DL, Zhou SY, Jiang EL, Huang Y, Wang HH, Zhai WJ, Zhou Z, Wang M, Feng SZ, Han MZ.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Aug 03; 25(8):458-61. PubMed ID: 15555259
    [Abstract] [Full Text] [Related]

  • 12. [Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia].
    Sun J, Meng FY, Liu QF, Xu D, Xu B, Liu XL.
    Ai Zheng; 2003 Dec 03; 22(12):1321-4. PubMed ID: 14693060
    [Abstract] [Full Text] [Related]

  • 13. Increase in FOXP3+ regulatory T cells in GVHD skin biopsies is associated with lower disease severity and treatment response.
    Fondi C, Nozzoli C, Benemei S, Baroni G, Saccardi R, Guidi S, Nicoletti P, Bartolozzi B, Pimpinelli N, Santucci M, Bosi A, Massi D.
    Biol Blood Marrow Transplant; 2009 Aug 03; 15(8):938-47. PubMed ID: 19589483
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The correlated research of acute graft versus host disease after allogeneic stem cell transplantation].
    Yang F, Chen H, Liu GX, Lu M, Feng K, Zhang YG, Zhang J.
    Zhonghua Xue Ye Xue Za Zhi; 2006 Apr 03; 27(4):264-8. PubMed ID: 16875562
    [Abstract] [Full Text] [Related]

  • 17. Low percentages of circulating CD8(+)/CD45RA(+) human T lymphocytes expressing beta7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Avanzini MA, Maccario R, Locatelli F, Giebel S, Santos CD, Bernardo ME, Pagliara D, Montagna D, Longo S, Amendola G, Marconi M.
    Exp Hematol; 2006 Oct 03; 34(10):1429-34. PubMed ID: 16982336
    [Abstract] [Full Text] [Related]

  • 18. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ, Min WS, Cho BS, Eom KS, Kim YJ, Min CK, Lee S, Cho SG, Jin JY, Lee JW, Kim CC.
    Biol Blood Marrow Transplant; 2009 Jun 03; 15(6):704-17. PubMed ID: 19450755
    [Abstract] [Full Text] [Related]

  • 19. High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation.
    Labbé AC, Su SH, Laverdière M, Pépin J, Patiño C, Cohen S, Kiss T, Lachance S, Sauvageau G, Busque L, Roy DC, Roy J.
    Biol Blood Marrow Transplant; 2007 Oct 03; 13(10):1192-200. PubMed ID: 17889356
    [Abstract] [Full Text] [Related]

  • 20. Elevated Fas/FasL system and endothelial cell microparticles are involved in endothelial damage in acute graft-versus-host disease: a clinical analysis.
    Wu Q, Chen H, Fang J, Xie W, Hong M, Xia L.
    Leuk Res; 2012 Mar 03; 36(3):275-80. PubMed ID: 21917312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.